Kiniksa Pharmaceuticals International, plc (KNSA) › Total AssetsKiniksa Pharmaceuticals International, plc (KNSA) — Total AssetsAnnual figures by fiscal year, from SEC filings.2017: $47.49M2018: $321.96M2019: $254.53M2020: $349.46M2021: $232.80M2022: $459.67M2023: $526.32M2024: $580.55M2025: $763.63M$763.63M2017Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$763.63M+31.5%2024$580.55M+10.3%2023$526.32M+14.5%2022$459.67M+97.5%2021$232.80M-33.4%2020$349.46M+37.3%2019$254.53M-20.9%2018$321.96M+577.9%2017$47.49M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share